Annual Retained Earnings
-$947.22 M
-$243.79 M-34.66%
December 31, 2024
Summary
- As of March 7, 2025, NMRA annual retained earnings is -$947.22 million, with the most recent change of -$243.79 million (-34.66%) on December 31, 2024.
- During the last 3 years, NMRA annual retained earnings has fallen by -$610.62 million (-181.40%).
- NMRA annual retained earnings is now -4510476.19% below its all-time high of -$21.00 thousand, reached on December 1, 2019.
Performance
NMRA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$947.22 M
-$58.82 M-6.62%
December 31, 2024
Summary
- As of March 7, 2025, NMRA quarterly retained earnings is -$947.22 million, with the most recent change of -$58.82 million (-6.62%) on December 31, 2024.
- Over the past year, NMRA quarterly retained earnings has dropped by -$58.82 million (-6.62%).
- NMRA quarterly retained earnings is now -853.97% below its all-time high of -$99.29 million, reached on December 1, 2020.
Performance
NMRA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NMRA Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.7% | -6.6% |
| 3 y3 years | -181.4% | -131.0% |
| 5 y5 years | -10000.0% | -131.0% |
NMRA Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -181.4% | at low | -149.5% | at low |
| 5 y | 5-year | <-9999.0% | at low | -854.0% | at low |
| alltime | all time | <-9999.0% | at low | -854.0% | at low |
Neumora Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$947.22 M(+34.7%) | -$947.22 M(+6.6%) |
| Sep 2024 | - | -$888.40 M(+8.9%) |
| Jun 2024 | - | -$815.86 M(+7.8%) |
| Mar 2024 | - | -$757.15 M(+7.6%) |
| Dec 2023 | -$703.43 M(+50.5%) | -$703.43 M(+18.3%) |
| Sep 2023 | - | -$594.70 M(+9.8%) |
| Jun 2023 | - | -$541.68 M(+15.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -$467.51 M(+38.9%) | -$467.51 M(+14.0%) |
| Jun 2022 | - | -$410.02 M(+8.0%) |
| Mar 2022 | - | -$379.65 M(+12.8%) |
| Dec 2021 | -$336.61 M(+239.0%) | - |
| Dec 2021 | - | -$336.61 M(+8.7%) |
| Sep 2021 | - | -$309.64 M(+211.8%) |
| Dec 2020 | -$99.29 M(>+9900.0%) | -$99.29 M |
| Dec 2019 | -$21.00 K | - |
FAQ
- What is Neumora Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Neumora Therapeutics?
- What is Neumora Therapeutics annual retained earnings year-on-year change?
- What is Neumora Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly retained earnings year-on-year change?
What is Neumora Therapeutics annual retained earnings?
The current annual retained earnings of NMRA is -$947.22 M
What is the all time high annual retained earnings for Neumora Therapeutics?
Neumora Therapeutics all-time high annual retained earnings is -$21.00 K
What is Neumora Therapeutics annual retained earnings year-on-year change?
Over the past year, NMRA annual retained earnings has changed by -$243.79 M (-34.66%)
What is Neumora Therapeutics quarterly retained earnings?
The current quarterly retained earnings of NMRA is -$947.22 M
What is the all time high quarterly retained earnings for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly retained earnings is -$99.29 M
What is Neumora Therapeutics quarterly retained earnings year-on-year change?
Over the past year, NMRA quarterly retained earnings has changed by -$58.82 M (-6.62%)